Cargando…
1431. Evaluation of Drug-induced Liver Injury in Patients Receiving Anti-tuberculosis Medications and Subsequent Management
BACKGROUND: For anti-tubercular medications, the risk of drug-induced liver injury (DILI) ranges from 5-33%. DILI may be asymptomatic or may present with fever, nausea, vomiting, anorexia, and lethargy. The objective of this review is to describe the incidence of hepatotoxicity occurring with anti-t...
Autores principales: | Acosta, Carina, Barsoum, Barbara, Doan, Thien-Ly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752674/ http://dx.doi.org/10.1093/ofid/ofac492.1260 |
Ejemplares similares
-
341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab
por: Barsoum, Barbara, et al.
Publicado: (2021) -
657. Evaluating Clinical Outcomes of Bacteremic Patients Treated with AmpC-Inducing Versus -Stable Agents
por: Barsoum, Barbara, et al.
Publicado: (2022) -
103. Evaluating The Appropriateness of Vaccine Administration in Patients with Splenectomy
por: Barsoum, Barbara, et al.
Publicado: (2022) -
1431. Comparison of Treatment Outcomes with Definitive Antibiotic Therapy and Empiric Antibiotic Therapy in Osteomyelitis
por: Holzum, Dorothy, et al.
Publicado: (2019) -
1431. Dosing Matters – Consistency Analysis of Touch-Free Automatic Hand Hygiene Dispensers
por: Arbogast, James W, et al.
Publicado: (2023)